Giordano Natasha 4
4 · PLx Pharma Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
Giordano Natasha
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2022-02-22+300,000→ 300,000 totalExercise: $4.99Exp: 2032-02-22→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
- [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.